BF Biosciences Limited (PSX:BFBIO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
126.07
-2.58 (-2.01%)
At close: Oct 19, 2026

BF Biosciences Cash Flow Statement

Millions PKR. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
632.13447.15385.41149.05306.98
Depreciation & Amortization
273.58191.9235.5733.7828
Other Amortization
1.851.690.550.55-
Loss (Gain) From Sale of Assets
-2.99-2.79-2.13-1.06-
Loss (Gain) From Sale of Investments
-93.89-27.3-0.21-8.93-
Provision & Write-off of Bad Debts
4.57-14.28---
Other Operating Activities
300.8256.07305.4932.12-156.98
Change in Accounts Receivable
-169.427.99-110.82-41.1-
Change in Inventory
-1,363-858.15-41.57-445.69-
Change in Accounts Payable
432.36472.43196.75-5.94-
Change in Unearned Revenue
22.36-5.2719.75-17.78-
Change in Other Net Operating Assets
-64.910.32-124.09108.94-
Operating Cash Flow
-26.51299.79664.7-196.07178
Operating Cash Flow Growth
--54.90%---68.77%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-603.06-324.37-143.13-1,968-1,130
Sale of Property, Plant & Equipment
6.493.864.41.06-
Sale (Purchase) of Intangibles
-5.09-5.12--1.66-
Investment in Securities
949.56-1,100108.581,161-
Other Investing Activities
-74.659116.3483.4-333
Investing Cash Flow
273.25-1,335-13.81-724.44-1,463

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
206.21----
Long-Term Debt Issued
-93.55-811.02-
Total Debt Issued
206.2193.55-811.02-
Short-Term Debt Repaid
--231.86---
Long-Term Debt Repaid
-442.52-436.19-321.36-50.5-
Total Debt Repaid
-442.52-668.04-321.36-50.5-
Net Debt Issued (Repaid)
-236.31-574.49-321.36760.52-
Issuance of Common Stock
-1,855---
Other Financing Activities
-83.52-112.25-161.52-120.28925
Financing Cash Flow
-319.841,168-482.88640.24925

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Miscellaneous Cash Flow Adjustments
----1
Net Cash Flow
-73.09133.18168.02-280.27-359

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-629.57-24.59521.57-2,164-952
Free Cash Flow Growth
-----
Free Cash Flow Margin
-6.65%-0.42%14.26%-119.61%-62.60%
Free Cash Flow Per Share
-7.13-0.308.23-34.17-15.03
Levered Free Cash Flow
-783.86-254.99313.25-2,306-834
Unlevered Free Cash Flow
-729.61-185.18400.58-2,306-792.99

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
83.52112.25161.52120.28-
Cash Income Tax Paid
310.69282.2551.3973.4-
Change in Working Capital
-1,143-352.68-59.98-401.58-